Ruthenium-106 brachytherapy and intravitreal bevacizumab for retinal capillary hemangioma
Authors:
- 22 January 2012
- journal article
- case report
- Published by Springer Nature in International Ophthalmology
- Vol. 32 (1) , 71-75
Abstract
The purpose of this study is to report a case of retinal capillary hemangioma treated with ruthenium-106 brachytherapy combined with intravitreal bevacizumab. A 58-year-old woman presented with blurred vision in her left eye for 15 days. Best-corrected visual acuity (BCVA) was counting fingers at 3 m in her left eye. Examination showed a peripheral endophytic retinal capillary hemangioma, with associated macular edema and diffuse hard exudates in a macular star pattern. B-scan ultrasonography revealed a solid, highly reflective retinal tumor measuring 7.1 × 7.5 mm in basal dimension and 3.5 mm in thickness. The hemangioma and macular edema were treated with ruthenium-106 brachytherapy (500 Gy) followed 1 month later with an intravitreal injection of 1.25 mg (0.05 ml) bevacizumab. After 10 months of follow-up, examination demonstrated involution of the hemangioma, resolution of the macular edema, less hard exudates, and improvement of BCVA to 20/25. Ruthenium-106 brachytherapy combined with intravitreal bevacizumab was associated with significant involution of the choroidal hemangioma with resolution of the macular edema and improvement in visual acuity.Keywords
This publication has 7 references indexed in Scilit:
- INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY VITREOUS HEMORRHAGERetina, 2006
- Ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal haemangioma in Sturge-Weber syndromeIndian Journal Of Ophthalmology, 2005
- TREATMENT OF ANGIOMATOUS LESIONS OF THE RETINA WITH PHOTODYNAMIC THERAPYRetina, 2002
- VHL Gene Deletion and Enhanced VEGF Gene Expression Detected in the Stromal Cells of Retinal AngiomaArchives of Ophthalmology (1950), 1999
- A clinical and molecular genetic analysis of solitary ocular angiomaOphthalmology, 1999
- Ruthenium-106 brachytherapy for peripheral retinal capillary hemangiomaOphthalmology, 1998
- Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau diseaseAnnals of Oncology, 1997